Boston Partners Grows Holdings in Lam Research Corporation $LRCX

Boston Partners increased its position in Lam Research Corporation (NASDAQ:LRCX) by 36.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,202,925 shares of the semiconductor company’s stock after buying an additional 852,563 shares during the period. Boston Partners owned about 0.25% of Lam Research worth $311,763,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in shares of Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after acquiring an additional 12,936 shares during the last quarter. Alps Advisors Inc. raised its stake in shares of Lam Research by 294.2% in the 1st quarter. Alps Advisors Inc. now owns 17,537 shares of the semiconductor company’s stock valued at $1,275,000 after acquiring an additional 13,088 shares during the period. Mutual of America Capital Management LLC purchased a new position in Lam Research in the first quarter valued at about $13,345,000. Stephens Inc. AR raised its holdings in shares of Lam Research by 55.0% during the 1st quarter. Stephens Inc. AR now owns 9,603 shares of the semiconductor company’s stock valued at $698,000 after buying an additional 3,409 shares during the period. Finally, Westmount Partners LLC acquired a new position in shares of Lam Research during the first quarter worth $225,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the transaction, the director owned 1,652 shares in the company, valued at approximately $264,303.48. This represents a 44.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Ava Harter sold 9,010 shares of Lam Research stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 62,528 shares of company stock valued at $8,880,448 in the last quarter. Company insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on LRCX. Stifel Nicolaus set a $160.00 price target on Lam Research and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn boosted their price objective on Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. JPMorgan Chase & Co. increased their target price on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $170.00 target price on shares of Lam Research in a research report on Thursday, October 23rd. Finally, KeyCorp boosted their price target on Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $148.54.

Lam Research Stock Up 4.4%

Shares of Lam Research stock opened at $166.37 on Tuesday. The stock has a market capitalization of $208.97 billion, a price-to-earnings ratio of 36.65, a PEG ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $167.15. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The business’s 50 day simple moving average is $136.27 and its 200-day simple moving average is $107.57.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.